ArticleInvestigative and clinical urology2024

Short-term outcomes of intravesical gemcitabine for non-muscle-invasive bladder cancer after recent approval for use in Korea.

Gang Kyu Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.